Evidence review

BPC-157 for Long-Term PPI Users: Evidence Review

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-157-ppi`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-157-ppi

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-157-ppi/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-157-ppi/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-157-ppi/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-157-ppi/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have PPIs (omeprazole, etc.)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: BPC-157 is studied for local tissue repair by growing new blood vessels at an injury site. More blood supply → more healing material reaches damaged tissue. That is a regeneration pathway (build), not a suppression pathway (mute a signal).

Why BPC-157 might help you

  1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.
  2. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  3. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  4. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why PPIs (omeprazole, etc.) matters for you

  1. Drug: PPIs (omeprazole, etc.)
  2. What it does: Acid suppression; long-term mucosal and nutrient consequences.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • BPC-157 → structure / tissue

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 28
  • Reddit posts catalogued: 18
  • X posts catalogued: 8
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 30

Quantified confidence (this ledger): 0.8 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Proton Pump Inhibitors (PPIs): What They Are & Side Effects (source s1)

Overview of PPIs and documented long-term risks from clinical sources.

Evidence type: Published research.

Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats (source s2)

Rat study demonstrating BPC-157 effects on gastric ulcers.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon... (source s3)

Additional rat data on BPC-157 tissue repair (contextual for mechanism).

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Regeneration or Risk? A Narrative Review of BPC-157 for ... (source s4)

Review confirming limited human data and preclinical focus.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Bpc 157 oral — Reddit, r/GERD (source s5)

User and commenters report BPC-157 allowing significant PPI dose reduction and healing esophagitis when combined with PPI.

So frustrated. Oral BPC seems to be making my symptoms ... — Reddit, r/bpc_157 (source s6)

User reports oral BPC-157 worsening GERD and gastritis symptoms.

BPC-157 Seems to be Helping — Reddit, r/GERD (source s7)

Positive reports of BPC-157 reducing GERD symptoms and healing esophagus, often while tapering or after stopping PPIs.

BPC and healing esophagus from Gerd. — Reddit, r/bpc_157 (source s9)

Mixed: some users combine BPC with PPIs for healing; one comment notes BPC worsened symptoms.

PPIs, Standard of Care, Long Term Game Plan? — Reddit, r/EosinophilicE (source s11)

User with EoE on long-term PPI discusses using BPC-157 alongside diet and Dupixent, plans to wean PPI while continuing BPC for healing; notes symptom improvement but uncertain attribution.

ENOUGH IS ENOUGH! — Reddit, r/GERD (source s12)

OP on PPIs seeks alternatives, highlights interest in BPC-157 for gut healing in long-term GERD context; thread focuses on various experiences but no specific BPC outcomes detailed here.

BPC157 and IBS — Reddit, r/bpc_157 (source s16)

User on long-term PPI (dexlansoprazole) reports rapid resolution of acid reflux and bloating with oral BPC-157; positive sustained effects with as-needed use after 4+ months, planning potential long-term dependence.

BPC157 and IBS — Reddit, r/bpc_157 (source s17)

Comment reports physician anecdote of high success rate weaning long-term PPI users off medication after ~1 month of BPC-157.

GERD cured – experience share — Reddit, r/GERD (source s18)

User reports oral BPC-157 helping significantly with GERD symptoms.

Acid blocker medication ruined my gut health. I have dysbiosis, thrush and anxiety from a PPI. Can bpc-157 help me?? — Reddit, r/bpc_157 (source s20)

User reports long-term PPI (lansoprazole) use; BPC-157 (injected) reduced need to 1x/week. Anecdotal good outcome for reflux reduction. Another comment: PPI caused dysbiosis, white tongue, no appetite; hoping BPC help….

My cure: bpc157 — Reddit, r/GERD (source s21)

OP claims BPC-157 injections cured GERD after 2 years on 40mg omeprazole; symptoms gone in 4 weeks at 500mcg 2x/day for 2 months. Later notes symptoms returning after 6 months off. Anecdotal dosing/outcomes, good then….

Bpc and Omeprazole? — Reddit, r/bpc_157 (source s22)

Post asking about combining BPC-157 injections with PPI/omeprazole for potential benefit. No specific outcomes in snippet but directly on topic for long-term PPI users. (anecdotal context).

Has anyone ever tried the peptide BPC-157? — Reddit, r/Gastritis (source s23)

Discussion on BPC-157 for gut issues, referencing animal/experimental data on ulcer healing and mucosal protection, relevant to PPI-related damage. (anecdotal interest).

Can we talk BPC-157 for LPR? — Reddit, r/LPR (source s24)

Thread on BPC-157 for LPR/GERD, hypothesizing healing of esophageal damage from long-term acid issues (often managed with PPIs). Animal data cited. (anecdotal discussion).

Oral BPC-157 Has Given Me the First Symptom-Free Weeks of My Life — Reddit, r/bpc_157 (source s26)

Anecdotal report of oral BPC-157 (500-750 mcg daily) resolving long-term gut issues and allowing discontinuation of PPIs like omeprazole/Prilosec after years of dependence; multiple comments echo good outcomes with PP….

r/bpc_157
▲0▼
u/source
Oral BPC-157 Has Given Me the First Symptom-Free Weeks of My Life
Anecdotal report of oral BPC-157 (500-750 mcg daily) resolving long-term gut issues and allowing discontinuation of PPIs like omeprazole/Prilosec after years of dependence; multiple comments echo good outcomes with PPI reduction or cessation, dosing anecdotes (e.g., 1000 mcg pills daily), labeled anecdotal not advice; some mentions of potential side effects like anhedonia risk.
💬 0 comments↗ Share
2026-06-29 17:44s26 · #717a9074e3a9

Oral BPC-157 Has Given Me the First Symptom-Free Weeks of My Life — Reddit, r/bpc_157 (source s27)

Anecdotal positive outcome: BPC-157 (pills 1000 mcg/day) cured years of GERD, ended Prilosec use; part of thread on long-term PPI users finding relief.

What people say on X

Peptide Confessions post on BPC-157 and Omeprazole — X (source s8)

User reports complete resolution of long-term acid reflux after 3 weeks of oral BPC-157, allowing discontinuation of omeprazole.

Reply to peptide post on BPC-157 — X (source s10)

User planning to try BPC-157 after long-term omeprazole use, seeking to discontinue it.

X post by @1948IraqiLatinx — X (source s13)

Positive anecdotal report of sublingual/in-mouth BPC-157 resolving GERD symptoms and improving diet tolerance.

X post by @123456tag — X (source s14)

User reports BPC-157 eliminated GERD symptoms incidentally while treating shoulder injury.

X post by @CameronMaerz — X (source s15)

Positive report of ~1 month BPC-157 use leading to near-resolution of GERD and improved digestion.

X post recommending BPC-157 for GERD — X (source s19)

User recommends 60-day BPC-157 course to reset GI tract and address severe GERD from long-term issues.

X (source s25)

X post asking if oral BPC-157 + TB-500 could help with GERD (common in long-term PPI users). Anecdotal inquiry. (anecdotal, not advice).

X post about BPC-157 and PPI — X (source s30)

Anecdotal: Oral BPC-157 (LVLUP brand) reduced esophagus injury from acid reflux in context of long-term PPI use; positive outcome mentioned.

What we do not know

  1. There is a lack of large randomized human trials establishing the efficacy of BPC-157 for healing PPI-associated gut damage or reversing PPI side effects.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

PPIs · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBPC-157: Body Protection Compound · 24 humanAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Review · 7 humanBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid… · 6 human
Evidence · 30 sources · swipe →chain 0860f6e5004e · verify chain · provenance
1 / 30
r/bpc_157
▲0▼
u/source
Oral BPC-157 Has Given Me the First Symptom-Free Weeks of My Life
Anecdotal report of oral BPC-157 (500-750 mcg daily) resolving long-term gut issues and allowing discontinuation of PPIs like omeprazole/Prilosec after years of dependence; multiple comments echo good outcomes with PPI reduction or cessation, dosing anecdotes (e.g., 1000 mcg pills daily), labeled anecdotal not advice; some mentions of potential side effects like anhedonia risk.
💬 0 comments↗ Share
2026-06-29 17:44s26 · #717a9074e3a9
Evidence ledger 37 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
preclinical
Multiple rat studies show BPC-157 accelerating gastric ulcer healing compared with controls.
sources: s2, s3
system
Combinatorial mapping (transparent): bpc-157 vs ppis — regen=0.17, degen=0.65, Δ=-0.48. Method: layer_relevance(0.20) × evidence_factor(0.85); catalog.degen_score for PPIs (omeprazole, etc.).
system
BPC-157 for Long-Term PPI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
anecdotal
Some users claim that BPC-157 has allowed them to reduce or discontinue PPI use without worsening their symptoms.
sources: s5, s7, s8, s10
30 more ranked claims
anecdotal0.30
Positive anecdotal report of sublingual/in-mouth BPC-157 resolving GERD symptoms and improving diet tolerance.
grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.30
User reports BPC-157 eliminated GERD symptoms incidentally while treating shoulder injury.
grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.30
User recommends 60-day BPC-157 course to reset GI tract and address severe GERD from long-term issues.
grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.22low confidence
There is a lack of large randomized human trials establishing the efficacy of BPC-157 for healing PPI-associated gut damage or reversing PPI side effects.
kimi/moonshot-v1-8k
This claim directly addresses the explicit gaps mentioned in the instructions, specifying the type of studies that are missing and their relevance to the efficacy and safety of BPC-157.
sources: s4
mechanistic0.22
While human observational data suggests associations between long-term PPI use and various health risks, these associations do not necessarily imply causation, and further research is needed to establish direct causal links.
kimi/moonshot-v1-8k (adversary)
The original claim overstates the strength of the evidence by implying causation from observational data, which typically can only suggest associations. This counter-evidence provides a more nuanced view, emphasizing the need for further research to establish causality.
anecdotal0.22low confidence
User and commenters report BPC-157 allowing significant PPI dose reduction and healing esophagitis when combined with PPI.
grok/grok-4.3
Materialized from orphan source s5 by ledger repair
sources: s5
anecdotal0.22
User reports oral BPC-157 worsening GERD and gastritis symptoms.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
anecdotal0.22low confidence
Positive reports of BPC-157 reducing GERD symptoms and healing esophagus, often while tapering or after stopping PPIs.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
anecdotal0.22
User reports complete resolution of long-term acid reflux after 3 weeks of oral BPC-157, allowing discontinuation of omeprazole.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Mixed: some users combine BPC with PPIs for healing; one comment notes BPC worsened symptoms.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22
User planning to try BPC-157 after long-term omeprazole use, seeking to discontinue it.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22
Other users have reported that BPC-157 worsened their GERD and gastritis symptoms.
kimi/moonshot-v1-8k
This claim adds balance to the anecdotal evidence by including reports of adverse effects, which is important for a comprehensive understanding of user experiences with BPC-157.
sources: s6
anecdotal0.22low confidence
User with EoE on long-term PPI discusses using BPC-157 alongside diet and Dupixent, plans to wean PPI while continuing BPC for healing; notes symptom improvement but uncertain attribution.
grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
anecdotal0.22low confidence
OP on PPIs seeks alternatives, highlights interest in BPC-157 for gut healing in long-term GERD context; thread focuses on various experiences but no specific BPC outcomes detailed here.
grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22
Positive report of ~1 month BPC-157 use leading to near-resolution of GERD and improved digestion.
grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22
User on long-term PPI (dexlansoprazole) reports rapid resolution of acid reflux and bloating with oral BPC-157; positive sustained effects with as-needed use after 4+ months, planning potential long-term dependence.
grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22
Comment reports physician anecdote of high success rate weaning long-term PPI users off medication after ~1 month of BPC-157.
grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22
User reports oral BPC-157 helping significantly with GERD symptoms.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22
User reports long-term PPI (lansoprazole) use; BPC-157 (injected) reduced need to 1x/week. Anecdotal good outcome for reflux reduction. Another comment: PPI caused dysbiosis, white tongue, no appetite; hoping BPC helps. (anecdotal, not advice)
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22
OP claims BPC-157 injections cured GERD after 2 years on 40mg omeprazole; symptoms gone in 4 weeks at 500mcg 2x/day for 2 months. Later notes symptoms returning after 6 months off. Anecdotal dosing/outcomes, good then partial relapse. (anecdotal, not advice)
grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22
Post asking about combining BPC-157 injections with PPI/omeprazole for potential benefit. No specific outcomes in snippet but directly on topic for long-term PPI users. (anecdotal context)
grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22
Discussion on BPC-157 for gut issues, referencing animal/experimental data on ulcer healing and mucosal protection, relevant to PPI-related damage. (anecdotal interest)
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22low confidence
Thread on BPC-157 for LPR/GERD, hypothesizing healing of esophageal damage from long-term acid issues (often managed with PPIs). Animal data cited. (anecdotal discussion)
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22
X post asking if oral BPC-157 + TB-500 could help with GERD (common in long-term PPI users). Anecdotal inquiry. (anecdotal, not advice)
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
Anecdotal report of oral BPC-157 (500-750 mcg daily) resolving long-term gut issues and allowing discontinuation of PPIs like omeprazole/Prilosec after years of dependence; multiple comments echo good outcomes with PPI reduction or cessation, dosing anecdotes (e.g., 1000 mcg pills daily), labeled anecdotal not advice; some mentions of potential side effects like anhedonia risk.
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22
Anecdotal positive outcome: BPC-157 (pills 1000 mcg/day) cured years of GERD, ended Prilosec use; part of thread on long-term PPI users finding relief.
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22
Anecdotal experiences with oral BPC-157 for GERD/LPR symptoms in context of acid reflux sufferers (some implied long-term issues); dosing like 250 mcg twice daily; positive updates on symptom reduction, not directly PPI but related to PPI alternatives.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22
Anecdotal: BPC-157 (capsule opened, ~3 months use) helped LPR recovery alongside other factors; doctor-recommended for throat tissue; good outcome for inflammation/GERD-related issues, may overlap with PPI users.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
Anecdotal: Oral BPC-157 (LVLUP brand) reduced esophagus injury from acid reflux in context of long-term PPI use; positive outcome mentioned.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
Low-confidence / auto-generated 2
speculative0.12
Commercial vendors and clinics market this compound (3 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 9 duplicate marketing claims
sources: s2, s3, s4
speculative0.00downweightedlow confidence
Long-term PPI use is associated in human observational data with increased risks of nutrient malabsorption, fractures, kidney issues, and microbiome disruption.
system/unknown
Establishes baseline problem for the target audience of 15M long-term PPI users.
sources: s1
Model swipes · 16 from 6 models · swipe →verify
1 / 16
grok/grok-4.3writer
redraft2026-06-29 08:42
BPC-157 for Long-Term PPI Users: Evidence Review · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-for-long-term-ppi-users",
  "title": "BPC-157 for Long-Term PPI Users: Evidence Review",
  "body": "## Long-Term PPI Use and Associated Risks\n\nProton pump inhibitors (PPIs) reduce stomach acid production by blocking the proton pump in parietal cells. Long-term use is linked in human observational data to increased risks of nutrient malabsorption (e.g., vitamin B12, magnesium, calcium), bone fractures, kidney issues, and microbiome disruption. These effects stem from sustained acid suppression without addressing underlying mucosal damage.\n\n## BPC-157 Mechanism and Mapping to Gut Repair\n\nBPC-157 is a stable gastric pentadecapeptide derived from a gastric juice protein. In preclinical models it promotes angiogenesis and local tissue repair. No human clinical trials demonstrate BPC-157 healing of PPI-associated gut damage or reversal of PPI side effects. Human data on BPC-157 are limited to small, uncontrolled pilots for unrelated conditions.\n\n## Preclinical Evidence on Gastric Ulcers\n\nMultiple rat studies show BPC-157 accelerating gastric ulcer healing and providing cytoprotection, often outperforming controls in models of acute and chronic ulcers. These are separate from any PPI co-administration data, which do not exist in published literature.\n\n## Absence of Human Data\n\nNo published human trials or controlled studies examine BPC-157 in long-te
ab524d35db8c0186
grok-4.3source_hunt
sources2026-06-29 12:05
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
6 source(s) added
ad8b47697fef3ecb
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
{"materialized":0,"before":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
94111a2357222b25
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
{"materialized":0,"before":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
4281a0d6afa77670
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
{"materialized":0,"before":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
641d781fa13abc13
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
{"materialized":0,"before":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
a7bffc59669a6ce3
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
{"materialized":0,"before":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["6 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
749dccbefca25c60
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:34
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
I am adding explicit gaps in knowledge regarding BPC-157's long-term effects and safety in humans, as well as noting who claims what from anecdotes which were not fully detailed in the provided claims.
81b4fa564718a5d8
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 15:03
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
I am Gemini, not Grok. I added two tier-honest claims to the 'what_is_unknown' slot, highlighting critical gaps in human data regarding BPC-157's safety and optimal use, drawing from the provided review source (s4). I also challenged an existing meta-claim (c6) for an inaccuracy in its count of preclinical claims.
624afebd9ee964f3
grok/grok-4.3editor
synthesize_body2026-06-29 15:07
synthesize_body
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
## Regeneration vs degeneration — where this fits

The body breaks down tissue and builds it back at the same time. Long-term PPI use lowers stomach acid to stop damage. If repair does not keep up with the ongoing stress, the lining stays thin or inflamed. BPC-157 is studied for local repair steps that add blood supply and cell movement to the site. That is a build pathway, not a signal-suppression pathway.

## What it is

BPC-157 is a short chain of amino acids first taken from a stomach protein. It is examined in rat models of gut injury and tendon cuts. No approved human medicine uses it.

## How it works

Step 1: At an injury site, new small blood vessels form.  
Step 2: More blood brings oxygen, nutrients, and repair cells.  
Step 3: The extra supply speeds local tissue rebuilding in the models tested.  
Rat studies show this sequence in stomach ulcers and tendon cuts.

## Why it would work (logic chain)

If PPIs reduce acid but leave the lining thin, then adding blood flow and repair cells could close the gap. If the gap closes, symptoms tied to ongoing irritation could drop. The chain rests on the rat data; human steps remain untested.

## Why people take it

People on PPIs for years look for ways to reduce dose or stop the drug while keeping symptoms controlled. Some try BPC-157 because rat studies showed faster ulcer healing and because early user reports describe fewe
46bf2a1ee5199e78
grok-4.3source_hunt
sources2026-06-29 15:42
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
5 source(s) added
12e5c128f3715845
grok-4.3source_hunt
sources2026-06-29 15:43
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
4 source(s) added
0da4e50570f6332b
grok-4.3source_hunt
sources2026-06-29 17:43
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
6 source(s) added
2bf5ff0dc742386c
grok-4.3source_hunt
sources2026-06-29 17:44
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi
it output
5 source(s) added
a238748108562efc
fill-slotsclaim_post
claim2026-06-29 20:45
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi c44
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
8b3962f99ba3b96c
fill-slotsclaim_post
claim2026-06-29 20:45
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-ppi c44
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
dec1b44b21a9a59e

Related research

PPIs · drug map

Open evidence map →
BPC-157: Body Protection Compoundembedded in this articlebpc-157Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid…bpc-157-adderall-gutBPC 157 for Benzo Withdrawalbpc-157-benzo-withdrawalBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Reviewbpc-157-benzo-withdrawal-gutBPC 157 for Benzodiazepinesbpc-157-benzodiazepinesBPC 157 for Brain Fogbpc-157-brain-fogBPC 157 for Carpal Tunnelbpc-157-carpal-tunnelBPC 157 for Chemobpc-157-chemoBPC 157 for Chemo Neuropathybpc-157-chemo-neuropathy
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask bpc-157-ppi claim c44 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-157-ppi claim c9 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Multiple rat studies show BPC-157 accelerating gastric ulcer healing compared with controls."?
ask bpc-157-ppi claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "While human observational data suggests associations between long-term PPI use and various health risks, these associations do not necessari…"?
ask bpc-157-ppi claim c19 · paste includes §SELF
What does the ledger say about this (system tier): "Combinatorial mapping (transparent): bpc-157 vs ppis — regen=0.17, degen=0.65, Δ=-0.48. Method: layer_relevance(0.20) × evidence_factor(0.85…"?
ask bpc-157-ppi claim c_map_bpc-157-ppi · paste includes §SELF
What does the ledger say about this (system tier): "BPC-157 for Long-Term PPI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-ch…"?
ask bpc-157-ppi claim c43 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User and commenters report BPC-157 allowing significant PPI dose reduction and healing esophagitis when combined with PP"
ask bpc-157-ppi source s5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports oral BPC-157 worsening GERD and gastritis symptoms."
ask bpc-157-ppi source s6 · paste includes §SELF
bpc-157-ppi · posted 2026-06-29 · updated 2026-06-29 · 24 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 24 model passes · 12768 tokens · $0 · 7 models
chain head 7134119ed1506940
write grok/grok-4.3 · 2026-06-29 08:42 · 0 tok · a9845c9269e8
sources grok-4.3 · 2026-06-29 12:05 · 0 tok · da7f81571a4d
repair system/audit-repair · 2026-06-29 12:47 · 0 tok · 42c9a16c1936
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 7b9a5707792b
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 29f3c7e56d11
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · d15304525931
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 38d401071e4a
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 08f3f1d022b9
repair system/audit-repair · 2026-06-29 12:47 · 0 tok · 7fa951adbcc8
repair system/audit-repair · 2026-06-29 12:50 · 0 tok · 8144604a8e71
repair system/audit-repair · 2026-06-29 12:50 · 0 tok · 5a3ee2d83f28
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · e5dd1af28411
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · 2f4aa54f9e79
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:34 · 3548 tok · c5022067768c
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · d70f56045715
collaborate gemini/gemini-2.5-flash · 2026-06-29 15:03 · 3365 tok · 25b780a088bb
synthesize_body grok/grok-4.3 · 2026-06-29 15:07 · 5855 tok · 10c40cf0dd1d
sources grok-4.3 · 2026-06-29 15:42 · 0 tok · b11986e13a04
sources grok-4.3 · 2026-06-29 15:43 · 0 tok · dbe8163d920d
sources grok-4.3 · 2026-06-29 17:43 · 0 tok · d616c2f39723
sources grok-4.3 · 2026-06-29 17:44 · 0 tok · 4cb5401a5fb5
repair repair · 2026-06-29 19:31 · 0 tok · 38fa58779bfc
claim fill-slots · 2026-06-29 20:45 · 0 tok · bb3ed4867413
claim fill-slots · 2026-06-29 20:45 · 0 tok · 7134119ed150
verify chain →
Live ledger · 26 payloads · 6 turns
recent activity · inspect
webhook_in blooio · 2026-06-29 17:45
webhook_in blooio · 2026-06-29 17:45
webhook_in blooio · 2026-06-29 17:44
webhook_in blooio · 2026-06-29 17:44
PROTOCOL_RUN dispatch · 2026-06-29 15:43 · t_exwo3cg9
PROTOCOL_RUN dispatch · 2026-06-29 15:43 · t_exwo3cg9
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-157-ppi · GET /api/articles/bpc-157-ppi?format=post (the editable body)
create/replace POST /api/articles/bpc-157-ppi · PUT /api/articles/bpc-157-ppi (replace, keeps revision) · PATCH /api/articles/bpc-157-ppi (merge)
delete DELETE /api/articles/bpc-157-ppi
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-157-ppi/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-157-ppi/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-157-ppi|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →